WEBSITE BSE:533317 NSE: OMKAR SPC Inc. Year: 2005 Industry: Chemicals My Bucket: Add Stock
Last updated: 15:46
Omkar Speciality Chemicals Ltd is an Indian publicly listed specialty chemicals manufacturer that was originally founded as a proprietary concern called Omkar Chemicals in 1983 and later incorporated as a company in 2005, eventually converting to a public limited company in 2010. The company is headquartered in Badlapur, Thane, Maharashtra and is listed on Indian stock exchanges under the ticker OMKARCHEM. Its core business is the manufacture and sale of specialty chemicals and chemical intermediates that span a broad range of organic, inorgani...Read More
Omkar Speciality Chemicals Ltd is an Indian publicly listed specialty chemicals manufacturer that was originally founded as a proprietary concern called Omkar Chemicals in 1983 and later incorporated as a company in 2005, eventually converting to a public limited company in 2010. The company is headquartered in Badlapur, Thane, Maharashtra and is listed on Indian stock exchanges under the ticker OMKARCHEM. Its core business is the manufacture and sale of specialty chemicals and chemical intermediates that span a broad range of organic, inorganic and organo‑inorganic products, including derivatives of selenium, iodine, molybdenum, cobalt, bismuth and tungsten, as well as tartaric acid derivatives and other intermediates. These chemicals serve as essential inputs for diverse industries such as pharmaceuticals, chemicals, glass and ceramics, cosmetics, fragrances and flavours, and cattle & poultry feeds, and the company exports to markets in Europe, the Americas, Asia and Australia. Over the years, Omkar has expanded its manufacturing footprint with multiple production units in Maharashtra and has developed research and development capabilities, including acquiring a subsidiary to support innovation and diversification. Despite its long history and product breadth, its recent financial performance has shown modest revenues compared with past peak levels, characteristic of a small‑cap speciality player navigating competitive and cyclical industry conditions. Leadership includes Pravin S. Herlekar as Chairman and Managing Director, and the company continues to maintain operations focused on chemical intermediates while seeking to sustain growth and market relevance in both domestic and international markets. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹9 Cr.
Stock P/E 4.3
P/B -
Current Price ₹4.2
Book Value ₹ 0
Face Value 10
52W High ₹8.1
Dividend Yield 0%
52W Low ₹ 3.6
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 14 | 13 | 5 | 17 | 12 | 11 | 7 | 4 | 6 | 4 |
| Other Income | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Total Income | 14 | 13 | 6 | 17 | 13 | 11 | 7 | 5 | 6 | 4 |
| Total Expenditure | 14 | 15 | 5 | 14 | 9 | 11 | 8 | 7 | 6 | 5 |
| Operating Profit | 0 | -2 | 1 | 3 | 4 | 0 | -0 | -2 | 0 | -1 |
| Interest | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -3 | -4 | -1 | 1 | 1 | 3 | -2 | -4 | -2 | -3 |
| Provision for Tax | 1 | 1 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -4 | -5 | -1 | 0 | 1 | 3 | -2 | -4 | -2 | -3 |
| Adjustments | -0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 |
| Profit After Adjustments | -4 | -5 | -1 | 0 | 1 | 3 | -2 | -4 | -2 | -3 |
| Adjusted Earnings Per Share | -2 | -2.6 | -0.7 | 0.1 | 0.3 | 1.3 | -1.1 | -1.7 | -0.9 | -1.4 |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 167 | 202 | 210 | 193 | 300 | 317 | 192 | 43 | 57 | 45 | 21 |
| Other Income | 4 | 6 | 6 | 5 | 9 | 2 | 4 | 3 | 0 | 1 | 1 |
| Total Income | 171 | 207 | 215 | 198 | 309 | 319 | 195 | 46 | 57 | 46 | 22 |
| Total Expenditure | 134 | 165 | 177 | 164 | 255 | 259 | 235 | 45 | 57 | 38 | 26 |
| Operating Profit | 37 | 42 | 39 | 34 | 54 | 60 | -40 | 1 | 0 | 8 | -3 |
| Interest | 8 | 7 | 12 | 11 | 17 | 22 | 26 | 15 | 5 | 6 | 6 |
| Depreciation | 6 | 6 | 6 | 2 | 4 | 11 | 8 | 8 | 7 | 4 | 0 |
| Exceptional Income / Expenses | 0 | 0 | -0 | 0 | 0 | -164 | -53 | 10 | 0 | 4 | 0 |
| Profit Before Tax | 23 | 29 | 21 | 20 | 33 | -137 | -127 | -12 | -11 | 3 | -11 |
| Provision for Tax | 7 | 8 | 6 | 3 | 11 | -27 | -23 | 5 | 3 | 1 | 0 |
| Profit After Tax | 16 | 21 | 15 | 18 | 22 | -109 | -104 | -17 | -15 | 2 | -11 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 16 | 21 | 15 | 18 | 22 | -109 | -104 | -17 | -15 | 2 | -11 |
| Adjusted Earnings Per Share | 8.4 | 10.6 | 7.4 | 8.7 | 10.8 | -53.1 | -50.5 | -8.2 | -7.1 | 1 | -5.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -21% | -38% | -32% | 0% |
| Operating Profit CAGR | 0% | 0% | -32% | 0% |
| PAT CAGR | 0% | 0% | -38% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -28% | -19% | -19% | -32% |
| ROE Average | 0% | 0% | -24% | -5% |
| ROCE Average | 12% | 2% | -21% | -3% |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 106 | 127 | 138 | 163 | 181 | -3 | -125 | -148 | -162 | -158 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 5 | 30 | 37 | 42 | 79 | 58 | 76 | 74 | 74 | 67 |
| Other Non-Current Liabilities | 2 | 2 | 2 | 4 | 10 | -13 | -15 | -10 | -6 | -5 |
| Total Current Liabilities | 104 | 124 | 164 | 180 | 176 | 251 | 184 | 180 | 185 | 177 |
| Total Liabilities | 217 | 283 | 342 | 389 | 447 | 293 | 120 | 97 | 90 | 80 |
| Fixed Assets | 36 | 44 | 43 | 68 | 78 | 82 | 76 | 68 | 53 | 28 |
| Other Non-Current Assets | 43 | 78 | 122 | 175 | 153 | 19 | 9 | 7 | 7 | 6 |
| Total Current Assets | 138 | 160 | 177 | 145 | 216 | 192 | 35 | 21 | 30 | 46 |
| Total Assets | 217 | 283 | 342 | 389 | 447 | 293 | 120 | 97 | 90 | 80 |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 41 | 31 | 22 | 18 | 12 | 1 | 4 | 1 | 0 | 0 |
| Cash Flow from Operating Activities | -0 | 0 | 24 | 53 | -14 | 107 | 26 | 1 | 4 | -16 |
| Cash Flow from Investing Activities | -32 | -45 | -43 | -76 | 17 | -120 | -64 | 11 | 2 | 17 |
| Cash Flow from Financing Activities | 22 | 36 | 15 | 17 | -8 | 16 | 35 | -14 | -5 | -1 |
| Net Cash Inflow / Outflow | -10 | -9 | -4 | -6 | -5 | 3 | -3 | -1 | 0 | -0 |
| Closing Cash & Cash Equivalent | 31 | 22 | 18 | 12 | 7 | 4 | 1 | 0 | 0 | 0 |
| # | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 8.38 | 10.6 | 7.44 | 8.72 | 10.8 | -53.14 | -50.52 | -8.2 | -7.11 | 0.98 |
| CEPS(Rs) | 11.24 | 13.49 | 10.55 | 9.67 | 12.88 | -47.85 | -46.56 | -4.32 | -3.91 | 2.71 |
| DPS(Rs) | 1.25 | 1.5 | 1.5 | 1.5 | 1.5 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 53.92 | 62.77 | 68.46 | 79.18 | 88.17 | -1.37 | -60.79 | -71.96 | -78.96 | -76.94 |
| Core EBITDA Margin(%) | 18.76 | 16.86 | 14.62 | 14.01 | 14.23 | 16.61 | -21.94 | -4.41 | -0.42 | 16.33 |
| EBIT Margin(%) | 17.67 | 16.91 | 14.43 | 15.43 | 15.63 | -33.32 | -50.81 | 7.26 | -11.22 | 19.32 |
| Pre Tax Margin(%) | 13.1 | 13.46 | 9.21 | 9.9 | 10.46 | -39.65 | -64.03 | -27.01 | -19.89 | 6.98 |
| PAT Margin (%) | 9.29 | 9.65 | 6.49 | 8.68 | 6.96 | -31.7 | -52.6 | -39.56 | -25.73 | 4.46 |
| Cash Profit Margin (%) | 12.47 | 12.29 | 9.2 | 9.64 | 8.3 | -28.54 | -48.48 | -20.83 | -14.15 | 12.35 |
| ROA(%) | 8.45 | 8.33 | 4.68 | 4.91 | 5.32 | -29.57 | -50.33 | -15.57 | -15.68 | 2.36 |
| ROE(%) | 16.61 | 18.16 | 11.34 | 12.06 | 12.9 | -122.44 | 0 | 0 | 0 | 0 |
| ROCE(%) | 19.46 | 16.99 | 12.1 | 10.11 | 14.14 | -42.18 | -70.35 | 3.28 | -8.38 | 12.4 |
| Receivable days | 67.76 | 84.67 | 118.93 | 135.4 | 97.45 | 95.45 | 81.72 | 81.26 | 42.85 | 74.4 |
| Inventory Days | 85.34 | 98.45 | 102.64 | 103.93 | 66.6 | 70.24 | 69.57 | 30.91 | 21.6 | 20.84 |
| Payable days | 74.79 | 70.11 | 80.85 | 99.9 | 68.93 | 131.06 | 119.23 | 246.58 | 156.64 | 192 |
| PER(x) | 7.06 | 10.8 | 19.76 | 18.48 | 16.16 | 0 | 0 | 0 | 0 | 11.87 |
| Price/Book(x) | 1.1 | 1.82 | 2.15 | 2.03 | 1.98 | -111.43 | -0.54 | -0.22 | -0.03 | -0.15 |
| Dividend Yield(%) | 2.11 | 1.31 | 1.02 | 0.93 | 0.86 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.97 | 1.59 | 2.02 | 2.56 | 1.79 | 1.53 | 1.56 | 6.14 | 4.18 | 5.58 |
| EV/Core EBITDA(x) | 4.41 | 7.63 | 10.98 | 14.62 | 9.94 | 8.12 | -7.53 | 226.44 | 1146.9 | 30.58 |
| Net Sales Growth(%) | 56.38 | 20.71 | 4.01 | -7.78 | 55.2 | 5.57 | -39.51 | -77.74 | 33.35 | -20.66 |
| EBIT Growth(%) | 56.46 | 16.52 | -10.87 | -1.85 | 56.48 | -330.46 | 12.65 | 103.09 | -305.9 | 236.64 |
| PAT Growth(%) | 62.19 | 26.48 | -29.8 | 22.82 | 23.86 | -592.3 | 4.93 | 83.77 | 13.26 | 113.76 |
| EPS Growth(%) | 62.19 | 26.48 | -29.8 | 17.15 | 23.86 | -592.3 | 4.93 | 83.77 | 13.26 | 113.76 |
| Debt/Equity(x) | 0.74 | 0.96 | 1.15 | 1.08 | 1.02 | -64.17 | -1.86 | -1.55 | -1.44 | -1.44 |
| Current Ratio(x) | 1.32 | 1.29 | 1.08 | 0.81 | 1.23 | 0.76 | 0.19 | 0.12 | 0.16 | 0.26 |
| Quick Ratio(x) | 0.82 | 0.78 | 0.69 | 0.5 | 0.88 | 0.48 | 0.17 | 0.1 | 0.14 | 0.25 |
| Interest Cover(x) | 3.86 | 4.9 | 2.76 | 2.79 | 3.02 | -5.27 | -3.84 | 0.21 | -1.29 | 1.57 |
| Total Debt/Mcap(x) | 0.67 | 0.53 | 0.53 | 0.53 | 0.52 | 0.58 | 3.45 | 7.03 | 48.25 | 9.55 |
| # | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 27.62 | 27.62 | 27.62 | 27.62 | 27.62 | 27.62 | 17.62 | 17.62 | 14.71 | 14.71 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0.06 | 0.06 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 72.38 | 72.38 | 72.38 | 72.38 | 72.38 | 72.38 | 82.36 | 82.37 | 85.22 | 85.22 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.36 | 0.36 | 0.3 | 0.3 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 1.69 | 1.69 | 1.75 | 1.75 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.